Completed
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants
NCT04505722
- Conditions
- Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol
- Locations
-
- Synexus Clinical Research US Inc Birmingham, Alabama, United States
- University of Alabama Birmingham Birmingham, Alabama, United States
- Alabama Vaccine Research Clinic at UAB Birmingham, Alabama, United States
- Optimal Research Huntsville, Alabama, United States